Published in Arch Intern Med on August 08, 2001
Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA (2008) 6.50
Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol (2010) 2.68
Impact of social factors on risk of readmission or mortality in pneumonia and heart failure: systematic review. J Gen Intern Med (2012) 2.67
Depression and cardiovascular disease: healing the broken-hearted. JAMA (2006) 2.44
Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest (2008) 2.37
Multidimensional Prognostic Index based on a comprehensive geriatric assessment predicts short-term mortality in older patients with heart failure. Circ Heart Fail (2009) 1.83
Prevalence of major depressive episode in CKD. Am J Kidney Dis (2009) 1.79
Worsening depressive symptoms are associated with adverse clinical outcomes in patients with heart failure. J Am Coll Cardiol (2011) 1.71
A propensity matched study of New York Heart Association class and natural history end points in heart failure. Am J Cardiol (2006) 1.52
Effect of urgency symptoms on the risk of depression in community-dwelling elderly men. Korean J Urol (2013) 1.45
Antidepressant use, depression, and survival in patients with heart failure. Arch Intern Med (2008) 1.42
Predicting mortality in patients with heart failure: a pragmatic approach. Heart (2003) 1.42
The effects of depressive symptoms and anxiety on quality of life in patients with heart failure and their spouses: testing dyadic dynamics using Actor-Partner Interdependence Model. J Psychosom Res (2009) 1.35
Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function. Am Heart J (2006) 1.32
A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease. Kidney Int (2011) 1.31
Spiritual well-being and depression in patients with heart failure. J Gen Intern Med (2007) 1.31
Depression and prognosis following hospital admission because of acute myocardial infarction. CMAJ (2003) 1.25
Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia. Proc Natl Acad Sci U S A (2005) 1.24
Epidemiology, diagnosis, and management of depression in patients with CKD. Am J Kidney Dis (2009) 1.21
Living with and dying from heart failure: the role of palliative care. Heart (2002) 1.18
Safety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): a randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure. Am Heart J (2008) 1.18
Testing electronic algorithms to create disease registries in a safety net system. J Health Care Poor Underserved (2008) 1.17
Integrating co-morbid depression and chronic physical disease management: identifying and resolving failures in self-regulation. Clin Psychol Rev (2008) 1.16
Predictors of readmission and health related quality of life in patients with chronic heart failure: a comparison of different psychosocial aspects. J Behav Med (2010) 1.11
Clinical Psychology and Cardiovascular Disease: An Up-to-Date Clinical Practice Review for Assessment and Treatment of Anxiety and Depression. Clin Pract Epidemiol Ment Health (2011) 1.09
Neuropsychiatric complications of chronic kidney disease. Nat Rev Nephrol (2010) 1.08
Frequent hospital admission of older people with chronic disease: a cross-sectional survey with telephone follow-up and data linkage. BMC Health Serv Res (2012) 1.08
Quality of life in patients with heart failure: ask the patients. Heart Lung (2008) 1.06
Rationale, design and conduct of a randomised controlled trial evaluating a primary care-based complex intervention to improve the quality of life of heart failure patients: HICMan (Heidelberg Integrated Case Management). BMC Cardiovasc Disord (2007) 1.04
Depression, healthcare utilization, and death in heart failure: a community study. Circ Heart Fail (2013) 1.04
Marital status as an independent predictor of event-free survival of patients with heart failure. Am J Crit Care (2009) 1.01
Effectiveness of transcendental meditation on functional capacity and quality of life of African Americans with congestive heart failure: a randomized control study. Ethn Dis (2007) 1.00
Depression and cardiac function in patients with stable coronary heart disease: findings from the Heart and Soul Study. Psychosom Med (2008) 1.00
The relationship between depressive symptoms, health service consumption, and prognosis after acute myocardial infarction: a prospective cohort study. BMC Health Serv Res (2008) 0.99
Association of depression and survival in patients with chronic heart failure over 12 Years. Psychosomatics (2012) 0.99
Association of physical versus affective depressive symptoms with cardiac event-free survival in patients with heart failure. Psychosom Med (2012) 0.98
Living with depressive symptoms: patients with heart failure. Am J Crit Care (2009) 0.98
Mental disorders, quality of care, and outcomes among older patients hospitalized with heart failure: an analysis of the national heart failure project. Arch Gen Psychiatry (2008) 0.97
Depression is associated with cognitive dysfunction in older adults with heart failure. Cardiovasc Psychiatry Neurol (2011) 0.97
Predictors of All-Cause Mortality in Patients With Severe COPD and Major Depression Admitted to a Rehabilitation Hospital. Chest (2016) 0.96
Depression and major outcomes in older patients with heart failure. Arch Intern Med (2002) 0.95
Major depression and coronary flow reserve detected by positron emission tomography. Arch Intern Med (2009) 0.93
State of the Art Review: Depression, Stress, Anxiety, and Cardiovascular Disease. Am J Hypertens (2015) 0.93
Depression in patients with cardiovascular disease. Cardiol Res Pract (2012) 0.93
Depressive symptoms and poor social support have a synergistic effect on event-free survival in patients with heart failure. Heart Lung (2011) 0.93
Depressive symptoms increase risk of rehospitalisation in heart failure patients with preserved systolic function. J Clin Nurs (2009) 0.93
Psychobiology of depression/distress in congestive heart failure. Heart Fail Rev (2008) 0.92
Recognition and treatment of depression and anxiety symptoms in heart failure. Prim Care Companion J Clin Psychiatry (2009) 0.92
Psychological distress in primary care patients with heart failure: a longitudinal study. Br J Gen Pract (2007) 0.92
Self-assessment of health status is associated with inflammatory activation and predicts long-term outcomes in chronic heart failure. Eur J Heart Fail (2009) 0.92
Depressive symptoms after hospitalization in older adults: function and mortality outcomes. J Am Geriatr Soc (2012) 0.91
Quality of life in a diverse population of patients with heart failure: BASELINE FINDINGS FROM THE HEART FAILURE ADHERENCE AND RETENTION TRIAL (HART). J Cardiopulm Rehabil Prev (2009) 0.90
Levosimendan: from basic science to clinical practice. Heart Fail Rev (2008) 0.90
Diagnosis and treatment of depression in patients with congestive heart failure: a review of the literature. Prim Care Companion CNS Disord (2013) 0.90
Serious mental illness and acute hospital readmission in diabetic patients. Am J Med Qual (2012) 0.90
The association of comorbid depression with intensive care unit admission in patients with diabetes: a prospective cohort study. Psychosomatics (2011) 0.89
The dilemma, causes and approaches to avoid recurrent hospital readmissions for patients with chronic heart failure. Heart Fail Rev (2012) 0.89
Predictors of re-hospitalization in patients with chronic heart failure. World J Cardiol (2012) 0.88
Depressive symptoms and heart failure: examining the sociodemographic variables. Clin Nurse Spec (2009) 0.88
A positive 2-item Patient Health Questionnaire depression screen among hospitalized heart failure patients is associated with elevated 12-month mortality. J Card Fail (2011) 0.88
Coping styles in heart failure patients with depressive symptoms. J Psychosom Res (2009) 0.88
Effect of depression on prognosis in heart failure. Heart Fail Clin (2011) 0.87
The older the better: are elderly study participants more non-representative? A cross-sectional analysis of clinical trial and observational study samples. BMJ Open (2012) 0.87
A propensity-matched study of the association of physical function and outcomes in geriatric heart failure. Arch Gerontol Geriatr (2007) 0.86
Association between depression and development of coronary artery disease: pathophysiologic and diagnostic implications. Vasc Health Risk Manag (2011) 0.86
Creating patient and family education web sites: design and content of the home parenteral nutrition family caregivers web site. Comput Inform Nurs (2011) 0.86
Perceived social support predicted quality of life in patients with heart failure, but the effect is mediated by depressive symptoms. Qual Life Res (2012) 0.85
Brief depression screening with the PHQ-2 associated with prognosis following percutaneous coronary intervention with paclitaxel-eluting stenting. J Gen Intern Med (2009) 0.85
The relationship between pain, fatigue, depression and functional performance in stable heart failure. Heart Lung (2015) 0.85
Treatment of depression in patients with congestive heart failure. Heart Fail Rev (2007) 0.85
Executive dysfunction and depressive symptoms associated with reduced participation of people with severe congestive heart failure. Am J Occup Ther (2011) 0.85
The ninety-nine percent: focusing on the patient to reduce readmissions. J Gen Intern Med (2014) 0.85
Religious struggle as a predictor of subsequent mental and physical well-being in advanced heart failure patients. J Behav Med (2011) 0.85
Cognitive therapy improves three-month outcomes in hospitalized patients with heart failure. J Card Fail (2011) 0.84
Association between mental health conditions and rehospitalization, mortality, and functional outcomes in patients with stroke following inpatient rehabilitation. BMC Health Serv Res (2011) 0.84
Depression in hemodialysis patients: the role of dialysis shift. Clinics (Sao Paulo) (2014) 0.83
Comparing patient and nurse specialist reports of causative factors of depression related to heart failure. Perspect Psychiatr Care (2010) 0.83
Commonalities and differences in correlates of depressive symptoms in men and women with heart failure. Eur J Cardiovasc Nurs (2012) 0.82
Heart Failure Functional Class Associated with Depression Severity But Not Anxiety Severity. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2016) 0.82
Depression, psychological distress, and quality of life in patients with cardioverter defibrillator with or without cardiac resynchronization therapy. Heart Vessels (2013) 0.82
The impact of anxiety, depression, and suicidality on quality of life and functional status of patients with congestive heart failure and hypertension: an observational cross-sectional study. Prim Care Companion J Clin Psychiatry (2010) 0.82
Antidepressants do not improve event-free survival in patients with heart failure when depressive symptoms remain. Heart Lung (2013) 0.82
Sociodemographic factors and depressive symptoms in hospitalized patients with heart failure. Exp Clin Cardiol (2010) 0.82
Psychiatric comorbidity and mortality among veterans hospitalized for congestive heart failure. Mil Med (2010) 0.82
Symptom perception in CHF: (why mind matters). Heart Fail Rev (2007) 0.81
Changes in Depressive Symptoms and Mortality in Patients With Heart Failure: Effects of Cognitive-Affective and Somatic Symptoms. Psychosom Med (2015) 0.81
Does depression impact cognitive impairment in patients with heart failure? Cardiol Res Pract (2012) 0.81
Rationale and design of the Chronic Kidney Disease Antidepressant Sertraline Trial (CAST). Contemp Clin Trials (2012) 0.81
Cognitive Function in Heart Failure Is Associated With Nonsomatic Symptoms of Depression But Not Somatic Symptoms. J Cardiovasc Nurs (2015) 0.81
Anxiety and depression in ethnic minorities with chronic heart failure. J Card Fail (2009) 0.81
Mood and health-related quality of life among pediatric patients with heart failure. Pediatr Cardiol (2012) 0.81
Cognition as a therapeutic target in late-life depression: potential for nicotinic therapeutics. Biochem Pharmacol (2013) 0.80
Inflammation Markers and Major Depressive Disorder in Patients With Chronic Heart Failure: Results From the Sertraline Against Depression and Heart Disease in Chronic Heart Failure Study. Psychosom Med (2015) 0.80
Depressive symptoms and hospital readmission in older adults. J Am Geriatr Soc (2014) 0.80
Medication adherence, depressive symptoms, and cardiac event-free survival in patients with heart failure. J Card Fail (2013) 0.80
Disease-specific depression and outcomes in chronic heart failure: a propensity score analysis. Compr Ther (2007) 0.80
Transcranial direct current stimulation and repetitive transcranial magnetic stimulation in consultation-liaison psychiatry. Braz J Med Biol Res (2013) 0.79
Depressive symptoms are associated with higher rates of readmission or mortality after medical hospitalization: A systematic review and meta-analysis. J Hosp Med (2016) 0.79
Health status and depression remission in patients with chronic heart failure: patient-reported outcomes from the SADHART-CHF trial. Circ Heart Fail (2012) 0.79
Additive clinical value of serum brain-derived neurotrophic factor for prediction of chronic heart failure outcome. Heart Vessels (2015) 0.79
The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA (1996) 17.62
Evaluating the yield of medical tests. JAMA (1982) 14.05
Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med (2011) 7.62
Regression modelling strategies for improved prognostic prediction. Stat Med (1984) 7.09
Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med (1994) 6.78
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med (1997) 6.19
Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N Engl J Med (1996) 5.94
Racial variation in the use of coronary-revascularization procedures. Are the differences real? Do they matter? N Engl J Med (1997) 5.80
Value of the history and physical in identifying patients at increased risk for coronary artery disease. Ann Intern Med (1993) 5.59
Outcome of acute myocardial infarction according to the specialty of the admitting physician. N Engl J Med (1996) 5.51
A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol (1989) 5.50
Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. N Engl J Med (1999) 4.53
Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. N Engl J Med (1995) 4.29
Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. N Engl J Med (1996) 4.25
Cost effectiveness of early discharge after uncomplicated acute myocardial infarction. N Engl J Med (2000) 4.19
1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol (1999) 4.15
Lyme carditis: cardiac abnormalities of Lyme disease. Ann Intern Med (1980) 4.12
Randomised controlled trial of psychological debriefing for victims of acute burn trauma. Br J Psychiatry (1997) 3.98
Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. N Engl J Med (1995) 3.69
Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med (1991) 3.63
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation (2000) 3.61
Referral patterns for coronary artery disease treatment: gender bias or good clinical judgment? Ann Intern Med (1992) 3.39
Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation (1995) 3.38
Scorecard cardiovascular medicine. Its impact and future directions. Ann Intern Med (1994) 3.32
Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell (1992) 3.24
Job strain and the prevalence and outcome of coronary artery disease. Circulation (1995) 3.22
Cancer in the offspring of radiation workers: a record linkage study. BMJ (1997) 3.13
Resuscitation preferences among patients with severe congestive heart failure: results from the SUPPORT project. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Circulation (1998) 3.11
The SUPPORT prognostic model. Objective estimates of survival for seriously ill hospitalized adults. Study to understand prognoses and preferences for outcomes and risks of treatments. Ann Intern Med (1995) 3.08
Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery disease. JAMA (1992) 3.06
A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med (1987) 3.04
Gata5 is required for the development of the heart and endoderm in zebrafish. Genes Dev (1999) 2.95
Fusion of host cell secondary lysosomes with the parasitophorous vacuoles of Leishmania mexicana-infected macrophages. J Protozool (1975) 2.93
Clinical data bases. Accomplishments and unrealized potential. Med Care (1985) 2.83
Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction. N Engl J Med (1996) 2.83
ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol (1996) 2.81
Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial. Lancet (1997) 2.80
Presentation of viral antigen controlled by a gene in the major histocompatibility complex. Nature (1990) 2.65
Promoting clinical involvement in hospital quality improvement efforts: the effects of top management, board, and physician leadership. Health Serv Res (1997) 2.65
Reducing the risk of cardiovascular disease: effects of a community-based campaign on knowledge and behavior. J Community Health (1977) 2.64
Comparison of predictions based on observational data with the results of randomized controlled clinical trials of coronary artery bypass surgery. J Am Coll Cardiol (1988) 2.59
Relationship between inositol polyphosphate production and the increase of cytosolic free Ca2+ induced by vasopressin in isolated hepatocytes. J Biol Chem (1984) 2.57
Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med (1997) 2.55
Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. Circulation (1995) 2.53
Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4- or IL-13-mediated signaling. J Immunol (1999) 2.53
Patient-specific predictions of outcomes in myocardial infarction for real-time emergency use: a thrombolytic predictive instrument. Ann Intern Med (1997) 2.52
Factors affecting sensitivity and specificity of exercise electrocardiography. Multivariable analysis. Am J Med (1984) 2.49
Alcohol and injury. A case-crossover study. Arch Fam Med (1995) 2.49
Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med (1999) 2.44
Cardiogenic shock complicating acute coronary syndromes. Lancet (2000) 2.42
Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes. J Immunol (1988) 2.35
Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes. Proc Natl Acad Sci U S A (1989) 2.32
Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice. Virology (1998) 2.31
Effects of mental stress on myocardial ischemia during daily life. JAMA (1997) 2.30
Oesophageal narrowing is common and frequently under-appreciated at endoscopy in patients with oesophageal eosinophilia. Aliment Pharmacol Ther (2014) 2.30
Randomised trial of magnesium in in-hospital cardiac arrest. Duke Internal Medicine Housestaff. Lancet (1997) 2.30
Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial. JAMA (2001) 2.29
Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa Investigators. Clin Chem (1998) 2.27
A comparison of vascularized and nonvascularized bone grafts for reconstruction of mandibular continuity defects. J Oral Maxillofac Surg (1997) 2.27
Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection. J Immunol (1996) 2.24
A comparison of U.S. and Canadian cardiac catheterization practices in detecting severe coronary artery disease after myocardial infarction: efficiency, yield and long-term implications. J Am Coll Cardiol (1999) 2.24
Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study. Lancet (2001) 2.23
Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial. J Am Coll Cardiol (1999) 2.23
Temporal lobe volumetric cell densities in temporal lobe epilepsy. Epilepsia (1984) 2.21
Mental stress--induced myocardial ischemia and cardiac events. JAMA (1996) 2.20
Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. Thorax (1997) 2.19
CD8+ T cells are the major lymphocyte subpopulation involved in the protective immune response to Toxoplasma gondii in mice. Clin Exp Immunol (1991) 2.10
Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. Circulation (1998) 2.09
Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA (1999) 2.08
Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol (1997) 2.08
Class I-induced resistance to natural killing: identification of nonpermissive residues in HLA-A2. Proc Natl Acad Sci U S A (1991) 2.07
Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. J Am Coll Cardiol (1996) 2.07
Health care utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection. Arch Dis Child (2001) 2.07
Cardiac rupture, mortality and the timing of thrombolytic therapy: a meta-analysis. J Am Coll Cardiol (1990) 2.06
Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker. Eur Heart J (2002) 2.06
The last word on GUSTO, for now. Ann Intern Med (1994) 2.02
Tissue distribution and clearance kinetics of non-transferrin-bound iron in the hypotransferrinemic mouse: a rodent model for hemochromatosis. Proc Natl Acad Sci U S A (1987) 2.02
Detecting gene copy number fluctuations in tumor cells by microarray analysis of genomic representations. Genome Res (2000) 1.99
Exercise treadmill score for predicting prognosis in coronary artery disease. Ann Intern Med (1987) 1.98
Unusual topography of bovine rhodopsin promoter-lacZ fusion gene expression in transgenic mouse retinas. Neuron (1991) 1.98
Microscopy of stained urine smears to determine the need for quantitative culture. J Clin Microbiol (1976) 1.92
Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. Circulation (1994) 1.91
Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators. J Am Coll Cardiol (1996) 1.91
Relationship between antecedent angina pectoris and short-term prognosis after thrombolytic therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. Am Heart J (1990) 1.90
Absence of sex bias in the referral of patients for cardiac catheterization. N Engl J Med (1994) 1.90
Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial. Circulation (1996) 1.87
Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis. Am J Respir Crit Care Med (1998) 1.84
Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes. Circulation (2001) 1.83
Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. J Am Coll Cardiol (1997) 1.80